Th is new edition of Viral Infections of Humans: Epidemiology and Control is a timely reference that provides scholars, teachers, and students of epidemiology and infectious diseases with a current, comprehensive summary of what is known about the causes and consequences of infection with every virus known to cause significant human infection, emphasizing its impact at the population level. It presents the latest concepts, methods, and technologies in epidemiology, detection, investigation, modeling, and intervention.
While chapters include core virologic and clinical knowledge that may have changed little in the years since the publication of the fifth edition, these chapters also reflect the variable, often substantial degree to which the epidemiology and approaches to control have evolved. The reference includes both updated and new chapters that either greatly expand on material covered only superficially in the previous edition or introduce viruses just recently discovered to affect human populations. Each chapter presents information in a uniform way, summarizing the methodology, biological characteristics, descriptive epidemiology, transmission, pathogenesis, control, and prevention for each virus.
Among the contents covered include authoritative information on more recent developments and discoveries such as coronavirus disease 2019 (COVID-19); updates on the rapid advances in control of hepatitis C, influenza, and human papilloma virus-related diseases; and other new developments in the field.
The expanded and updated sixth edition of Viral Infections of Humans offers a uniquely comprehensive perspective on viruses in humans, from agents of classic diseases (e.g., hepatitis, measles, polio, rabies, and yellow fever), to those with greatest pandemic impact (e.g., influenza and human immunodeficiency virus), to those discovered relatively recently (e.g., henipavirus, metapneumovirus, and norovirus). It is an essential reference for epidemiology, public health, and medical students; epidemiologists; academic and practicing public health professionals; infectious disease physicians; internists and pediatricians; biopharmaceutical industry professionals; health policy-makers; and fellows and other established professionals in these fields.
